Art

J-GLOBAL ID：200902179820164948   Reference number：02A0186353

The Natural History Model of Hepatitis C Virus Infection and the Economic Evaluation of Alpha Interferon Treatment.

C型肝炎ウイルス感染の自然進展モデルとインターフェロンα療法の経済学的評価

Author (4)： HAYASHIDA K (Kyoto Univ.) ,  NAGASUE I (Pfizer Pharmaceuticals, Inc.) ,  FUKUDA T (Univ. Tokyo) ,  GUNJI A (Seigakuin Univ.)
Material： Journal of Epidemiology  (J Epidemiol)
Volume： 12  Issue： 1  Page： 22-32  Publication year： Jan. 2002 
JST Material Number： L3909A  ISSN： 0917-5040  Document type： Article
Article type： 原著論文  Country of issue： Japan (JPN)  Language： ENGLISH (EN)

Thesaurus term： *chronic hepatitis C ,...

   To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=02A0186353&from=J-GLOBAL&jstjournalNo=L3909A") }}

JST classification (2)： Epidemiology  (GB03000E) ,  Treatment for infectious diseases,parasitic diseases.  (GD01030D)

Reference (27)：

• MARCELLIN, P. Long-term histologic improvement and loss of detectable intrahepatic HCV RNA in patients with chronic hepatitis C and sustained respones to interferon-α therapy. Ann Intern Med. 1997, 127, 875-881
• BENNETT, WG. Estimates of the cost-effectiveness of a single course of interferon-α 2b in patients with histologically mild chronic hepatitis C. Ann Intern Med. 1997, 127, 855-865
• KIM, WR. Cost-effectiveness of 6 and 12 months of interferon-α therapy for chronic hepatitis C. Ann Intern Med. 1997, 127, 866-874
• MORIGUCHI, H. The socioeconomic evaluation of strategical treatment for chronic hepatitis C with interferon. Jpn J Health Econ Policy. 1996, 3, 169-178
• WONG, JB. Cost-effectiveness of treatments for chronic hepatitis C. Am J Med. 1999, 107, 6B, 74S-78S

Terms in the title (7)： C型肝炎ウイルス感染 ,  進展 ,  モデル ,  インターフェロン ,  療法 ,  経済 ,  評価